Germany, Aug. 18 -- Germany based Novartis Pharma GmbH has secured contract from AOK Baden-Wurttemberg for Pharmaceutical Products - Pharmaceutical discount agreement in accordance with Section 130a (8) SGB V for the active ingredient ofatumumab. The value of the contract is worth 22100000 EUR.
Published by HT Digital Content Services with permission from Pivotal Sources....